this sounds really great. The phase 2 results look very good indeed. I hope the phase 3 trial can get started before too long and then the regulators will fast track it, seeing as it meets an unmet need, and it is already prescribed for diabetes, and it is cheap as chips. Seems like a no-brainer! (scuze the pun).